Dr. Yoon is a molecular biologist specializing in epigenetics, cancer biology, and fibrotic diseases. He has a laboratory at Avison Biomedical Research Center, Yonsei University School of Medicine, which has state-of-the-art research facilities and the largest animal lab in Korea, and has recently focused on developing targeted therapeutics for intractable & chronic diseases such as cancer and fibrotic diseases (IPF, NASH, CKD). To this end, he published a number of intellectual property rights and international academic journals, and transferred a number of technologies to Bio-companies. Furthermore, he is focusing on the development of therapeutic antibodies and compounds with the goal of developing targeted therapeutics for intractable tissue fibrosis diseases in the future.

Dr. Choi is a Professor at the Department of Biomedical Sciences, and Department of Pharmacology, University of Ulsan College of Medicine, Seoul, Korea. He received his BS degree and MS degree at Korea University, and received Ph.D. degree in Department of Biochemistry and Molecular Biology at Yonsei University College of Medicine in 2010. He developed his carrier when he worked as a postdoctoral training at the Department of Biochemistry and Molecular Biology, Yonsei University College of Medicine. Currently, he is a Professor at the University of Ulsan College of Medicine, Asan Medical Center (AMC) in Korea from 2011. His main focus of research is on the epigenetic regulation of cancer development and metastasis, and on the molecular mechanism of epigenetic regulators in cancer (GBM, Breast cancer, Pancreatic cancer, etc) and inflammation. Also, his research has focused on the discovery of novel epigenetic inhibitors, the development of humanized antibodies, and the screening of small compounds for the therapy of cancer cells and cancer stem cells.